2020
DOI: 10.1016/j.hrcr.2020.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent ventricular fibrillation with different tyrosine kinase inhibitors for chronic myeloid leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…However, direct evidence to connect protein kinases activity and cardiac abnormalities is still lacking. On the other hand, several studies showed that TKIs-induced cellular oxidative stress and alterations in cardiac structure and contractions [53][54][55][56][57][58] , suggesting that the "cardiotoxicity" from TKI most likely result from both on-and offtarget effects.…”
Section: Discussionmentioning
confidence: 99%
“…However, direct evidence to connect protein kinases activity and cardiac abnormalities is still lacking. On the other hand, several studies showed that TKIs-induced cellular oxidative stress and alterations in cardiac structure and contractions [53][54][55][56][57][58] , suggesting that the "cardiotoxicity" from TKI most likely result from both on-and offtarget effects.…”
Section: Discussionmentioning
confidence: 99%
“…And, both the PC tyrosine (TAT and TAC) kinases effect and angiotensin II-induced protection and are necessary for trigger mechanism of ischemic preconditioning [34]. And, the Src kinase activation mediates ischemic injury but triggers IPC in the position either upstream of or parallel to membrane associated PKC-ε [35].…”
Section: The Necessity Of Pyrimidine Kinases (Tat and Tac) In Acyl-co...mentioning
confidence: 99%